Ibnsina Pharma (EGX:ISPH)
Egypt · Delayed Price · Currency is EGP 11.39
+0.24 (2.15%)
At close: Oct 23, 2025
Ibnsina Pharma Revenue
Ibnsina Pharma had revenue of 18.00B EGP in the quarter ending June 30, 2025, with 47.09% growth. This brings the company's revenue in the last twelve months to 68.07B, up 61.83% year-over-year. In the year 2024, Ibnsina Pharma had annual revenue of 55.84B with 64.49% growth.
Revenue (ttm)
68.07B
Revenue Growth
+61.83%
P/S Ratio
0.17
Revenue / Employee
12.38M
Employees
5,500
Market Cap
11.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 55.84B | 21.89B | 64.49% |
| Dec 31, 2023 | 33.95B | 11.68B | 52.48% |
| Dec 31, 2022 | 22.26B | 531.66M | 2.45% |
| Dec 31, 2021 | 21.73B | 3.05B | 16.35% |
| Dec 31, 2020 | 18.68B | 2.08B | 12.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| El Sewedy Electric Company | 253.16B |
| Commercial International Bank Egypt (CIB) S.A.E. | 111.86B |
| Telecom Egypt Company | 94.68B |
| Qatar National Bank | 50.63B |
| Talaat Moustafa Group Holding | 50.04B |
| Egypt Aluminum | 43.18B |
| Eastern Company S.A.E | 37.38B |
| Misr Fertilizer Production Company | 23.05B |